Greenway Schond L. has filed 10 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 5560 shares of Definium Therapeutics, Inc. ($DFTX) on March 25, 2024.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2024 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | F | Common Shares | 5560 | $9.78 | 211,057.0000 | 0 | 2.57% | 0.00% |
| Feb. 27, 2024 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 5652 | $3.63 | 216,617.0000 | 0 | 2.54% | 0.00% |
| Sept. 25, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 1908 | $3.57 | 226,123.0000 | 0 | 0.84% | 0.00% |
| Sept. 25, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 3854 | $3.58 | 222,269.0000 | 0 | 1.70% | 0.00% |
| Aug. 25, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 20000 | $3.80 | 228,031.0000 | 0 | 8.06% | 0.00% |
| June 27, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 7694 | $3.19 | 251,972.0000 | 0 | 2.96% | 0.00% |
| June 27, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | S | Common Shares | 3941 | $3.21 | 248,031.0000 | 0 | 1.56% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | A | Common Shares | 175000 | $0.00 | 259,666.0000 | 0 | 206.69% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Greenway Schond L. | Chief Financial Officer | A | Common Shares | 175000 | $0.00 | 1,445,000.0000 | 0 | 13.78% | 0.00% |